MH

Mark R. Hellberg

AL Alcon Laboratories: 33 patents #1 of 314Top 1%
AL Alcon: 20 patents #18 of 866Top 3%
AU Alcon Universal: 10 patents #2 of 80Top 3%
AR Alcon Research: 6 patents #31 of 267Top 15%
SG Shire Orphan Therapies Gmbh: 6 patents #4 of 28Top 15%
AM Alcon Manufacturing: 5 patents #7 of 72Top 10%
AI A. H. Robins Company, Incorporated: 3 patents #21 of 80Top 30%
NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
YC Yamanouchi Pharmaceutical Co.: 1 patents #277 of 516Top 55%
AP Amerimas Home Products: 1 patents #421 of 715Top 60%
AP Astellas Pharma: 1 patents #544 of 954Top 60%
KA Kalypsys: 1 patents #22 of 42Top 55%
📍 Arlington, TX: #2 of 1,708 inventorsTop 1%
🗺 Texas: #555 of 125,132 inventorsTop 1%
Overall (All Time): #18,452 of 4,157,543Top 1%
89
Patents All Time

Issued Patents All Time

Showing 51–75 of 89 patents

Patent #TitleCo-InventorsDate
6353000 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension Verney L. Sallee, Peter G. Klimko, Paul W. Zinke 2002-03-05
6353012 15-Hydroxyeicosatetraenoic acid-related compounds and methods of use John M. Yanni, Gustav Graff, Daniel A. Gamache, Peter G. Klimko 2002-03-05
6353014 15-ketal postaglandins for the treatment of glaucoma or ocular hypertension Verney L. Sallee, Peter G. Klimko 2002-03-05
6342524 Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension Jon C. Nixon 2002-01-29
6331644 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use Peter G. Klimko, Gustav Graff 2001-12-18
6232344 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension Zixia Feng 2001-05-15
6225327 Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications Steven T. Miller, John M. Yanni 2001-05-01
6211226 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension Peter G. Klimko 2001-04-03
6200990 Neuroprotective agents having antioxidant and NMDA antagonist activity Abdelmoula Namil 2001-03-13
6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives Robert Selliah, Peter G. Klimko, Verney L. Sallee, Paul W. Zinke 2001-03-06
6172109 13-Thia prostaglandins for use in glaucoma therapy Paul W. Zinke 2001-01-09
6169111 Conformationally rigid aryl prostaglandins for use in glaucoma therapy Paul W. Zinke, John E. Bishop, Thomas R. Dean 2001-01-02
6166073 Combinations of DP and FP type prostaglandins for lowering IOP Thomas R. Dean, Verney L. Sallee 2000-12-26
6096783 Cyclobutane prostaglandin analogues as ocular hypotensive agents 2000-08-01
6066671 Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides John M. Yanni 2000-05-23
6025392 substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives Robert Selliah, Peter G. Klimko, Verney L. Sallee, Paul W. Zinke 2000-02-15
6022699 Myeloperoxidase assay of endotoxin-induced inflammation Gustav Graff 2000-02-08
5998465 Esters of non-steroidal anti-flammatory carboxylic acids Pete Delgado, Jon C. Nixon 1999-12-07
5965534 Use of .omega.-conotoxin analogs for treating retinal and optic nerve head damage Iok-Hou Pang, Michael A. Kapin 1999-10-12
5925673 Benzofurans and benzopyrans as cytoprotective agents Abdelmoula Namil, Jon C. Nixon 1999-07-20
5908849 Anti-oxidant esters of non-steroidal anti-inflammatory agents Pete Delgado, Jon C. Nixon 1999-06-01
5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents 1998-12-08
5811438 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products Gustav Graff, Daniel A. Gamache, Jon C. Nixon, William H. Garner 1998-09-22
5807892 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension Peter G. Klimko, Robert Selliah, Thomas R. Dean, John E. Bishop 1998-09-15
5750564 Anti-oxidant esters of non-steroidal anti-inflammatory agents Pete Delgado, Jon C. Nixon 1998-05-12